Savara Pharmaceuticals
SVRA
#6474
Rank
$0.57 B
Marketcap
$3.36
Share price
3.70%
Change (1 day)
-9.92%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -$75.29 Million USD

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -$54.7 Million USD a decrease over its 2022 earnings that were of -$38.15 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$75.29 Million37.64%
2023 -$54.7 Million43.38%
2022 -$38.15 Million-11.31%
2021 -$43.02 Million-13.3%
2020 -$49.62 Million-36.53%
2019 -$78.18 Million13.76%
2018 -$68.72 Million105.54%
2017 -$33.44 Million34.11%
2016 -$24.93 Million-37.43%
2015 -$39.85 Million38.81%
2014 -$28.71 Million33.62%
2013 -$21.49 Million38.49%
2012 -$15.52 Million24.59%
2011 -$12.45 Million-36.5%
2010 -$19.61 Million-3.14%
2009 -$20.25 Million-23.28%
2008 -$26.39 Million8.52%
2007 -$24.32 Million-34.14%
2006 -$36.92 Million184.43%
2005 -$12.98 Million90.75%
2004 -$6.81 Million190.35%
2003 -$2.35 Million11.64%
2002 -$2.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$18.16 Million-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.25 Billion 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA